|View printer-friendly version|
Industry leader strengthens interface with customers worldwide
WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today the promotion of Dr. Christophe Berthoux to the newly-created position of Executive Vice President, Global Sales and Marketing and Chief Commercial Officer. In this role, Dr. Berthoux will lead the global realignment of Charles River's Sales and Marketing organization, the goal of which is to further enhance the Company's interface with its customers.
"Given Dr. Berthoux's scientific and business training, his in-depth customer knowledge, as well as his considerable sales and marketing experience, I am confident that he will provide extraordinary levels of leadership in driving this newly created global organization," said James C. Foster, Chairman, President and Chief Executive Officer of Charles River.
Mr. Foster continued, "Our global Sales and Marketing organization will enhance the Company's ability to provide customers with a centralized, integrated approach to their drug development programs across all business segments. As our customers continue to transform their business models, we must evolve with them. We view a global Sales and Marketing organization as a milestone in the quest to truly become one with our customers."
About Charles River
Accelerating Drug Development. Exactly. Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies, and leading academic institutions around the globe accelerate their research and drug development efforts. Our more than 9,000 employees worldwide are focused on providing clients with exactly what they need to improve and expedite the discovery, development through first-in-human evaluation, and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.
Source: Charles River Laboratories International, Inc.